212 related articles for article (PubMed ID: 33527196)
1. CD30
Lam JH; Hong M; Koo SL; Chua CWL; Lim KL; Wee F; Wan WK; Leow WQ; Yeo JG; Tan IBH; Yeong J; Lim TKH; Lim TS
Cancer Immunol Immunother; 2021 Aug; 70(8):2353-2365. PubMed ID: 33527196
[TBL] [Abstract][Full Text] [Related]
2. The survival of memory CD4+ T cells within the gut lamina propria requires OX40 and CD30 signals.
Withers DR; Jaensson E; Gaspal F; McConnell FM; Eksteen B; Anderson G; Agace WW; Lane PJL
J Immunol; 2009 Oct; 183(8):5079-84. PubMed ID: 19786532
[TBL] [Abstract][Full Text] [Related]
3. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
[TBL] [Abstract][Full Text] [Related]
4. CD4⁺ T cells expressing latency-associated peptide and Foxp3 are an activated subgroup of regulatory T cells enriched in patients with colorectal cancer.
Mahalingam J; Lin CY; Chiang JM; Su PJ; Chu YY; Lai HY; Fang JH; Huang CT; Lin YC
PLoS One; 2014; 9(9):e108554. PubMed ID: 25268580
[TBL] [Abstract][Full Text] [Related]
5. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4
Toor SM; Murshed K; Al-Dhaheri M; Khawar M; Abu Nada M; Elkord E
Front Immunol; 2019; 10():2936. PubMed ID: 31921188
[TBL] [Abstract][Full Text] [Related]
6. TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4-1BB and OX40.
Hamano R; Huang J; Yoshimura T; Oppenheim JJ; Chen X
Eur J Immunol; 2011 Jul; 41(7):2010-20. PubMed ID: 21491419
[TBL] [Abstract][Full Text] [Related]
7. Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells.
Hippen KL; Harker-Murray P; Porter SB; Merkel SC; Londer A; Taylor DK; Bina M; Panoskaltsis-Mortari A; Rubinstein P; Van Rooijen N; Golovina TN; Suhoski MM; Miller JS; Wagner JE; June CH; Riley JL; Blazar BR
Blood; 2008 Oct; 112(7):2847-57. PubMed ID: 18645038
[TBL] [Abstract][Full Text] [Related]
8. 4-1BBL-containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells.
Swatler J; Turos-Korgul L; Brewinska-Olchowik M; De Biasi S; Dudka W; Le BV; Kominek A; Cyranowski S; Pilanc P; Mohammadi E; Cysewski D; Kozlowska E; Grabowska-Pyrzewicz W; Wojda U; Basak G; Mieczkowski J; Skorski T; Cossarizza A; Piwocka K
Blood Adv; 2022 Mar; 6(6):1879-1894. PubMed ID: 35130345
[TBL] [Abstract][Full Text] [Related]
9. FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer.
Zhuo C; Xu Y; Ying M; Li Q; Huang L; Li D; Cai S; Li B
Immunol Res; 2015 Mar; 61(3):338-47. PubMed ID: 25608795
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
[TBL] [Abstract][Full Text] [Related]
11. Mice deficient in OX40 and CD30 signals lack memory antibody responses because of deficient CD4 T cell memory.
Gaspal FM; Kim MY; McConnell FM; Raykundalia C; Bekiaris V; Lane PJ
J Immunol; 2005 Apr; 174(7):3891-6. PubMed ID: 15778343
[TBL] [Abstract][Full Text] [Related]
12. OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.
Jacquemin C; Augusto JF; Scherlinger M; Gensous N; Forcade E; Douchet I; Levionnois E; Richez C; Lazaro E; Duffau P; Truchetet ME; Seneschal J; Couzi L; Pellegrin JL; Viallard JF; Schaeverbeke T; Pascual V; Contin-Bordes C; Blanco P
JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568041
[TBL] [Abstract][Full Text] [Related]
13. Role of Thalidomide on the Expression of OX40, 4-1BB, and GITR in T Cell Subsets.
Kim BS; Kim JY; Kim EJ; Lee JG; Joo DJ; Huh KH; Kim MS; Kim YS
Transplant Proc; 2016 May; 48(4):1270-4. PubMed ID: 27320601
[TBL] [Abstract][Full Text] [Related]
14. Human OX40 tunes the function of regulatory T cells in tumor and nontumor areas of hepatitis C virus-infected liver tissue.
Piconese S; Timperi E; Pacella I; Schinzari V; Tripodo C; Rossi M; Guglielmo N; Mennini G; Grazi GL; Di Filippo S; Brozzetti S; Fazzi K; Antonelli G; Lozzi MA; Sanchez M; Barnaba V
Hepatology; 2014 Nov; 60(5):1494-507. PubMed ID: 24756990
[TBL] [Abstract][Full Text] [Related]
15. Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation.
Kumar P; Marinelarena A; Raghunathan D; Ragothaman VK; Saini S; Bhattacharya P; Fan J; Epstein AL; Maker AV; Prabhakar BS
Cell Mol Immunol; 2019 Feb; 16(2):138-153. PubMed ID: 29578532
[TBL] [Abstract][Full Text] [Related]
16. CD30 expression identifies the predominant proliferating T lymphocyte population in human alloimmune responses.
Chan KW; Hopke CD; Krams SM; Martinez OM
J Immunol; 2002 Aug; 169(4):1784-91. PubMed ID: 12165500
[TBL] [Abstract][Full Text] [Related]
17. IL-15 controls T cell functions through its influence on CD30 and OX40 antigens in Celiac Disease.
Periolo N; Guillén L; Arruvito ML; Alegre NS; Niveloni SI; Hwang JH; Bai JC; Cherñavsky AC
Cytokine; 2014 May; 67(1):44-51. PubMed ID: 24680481
[TBL] [Abstract][Full Text] [Related]
18. Blockade of tumor necrosis factor superfamily members CD30 and OX40 abrogates disease activity in murine immune-mediated glomerulonephritis.
Artinger K; Kirsch AH; Mooslechner AA; Cooper DJ; Aringer I; Schuller M; Schabhüttl C; Klötzer KA; Schweighofer K; Eller P; Yagita H; Illert AL; Rosenkranz AR; Lane PJ; Eller K
Kidney Int; 2021 Aug; 100(2):336-348. PubMed ID: 33785369
[TBL] [Abstract][Full Text] [Related]
19. The T-cell activation markers CD30 and OX40/CD134 are expressed in nonoverlapping subsets of peripheral T-cell lymphoma.
Jones D; Fletcher CD; Pulford K; Shahsafaei A; Dorfman DM
Blood; 1999 May; 93(10):3487-93. PubMed ID: 10233901
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil.
Ferreira CR; Zhao S; Sanches JA; Miyashiro D; Cury-Martins J; Azevedo RS; Zerbini MCN; Natkunam Y; Gratzinger D
Diagn Pathol; 2019 Oct; 14(1):115. PubMed ID: 31640798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
